This is an opinion piece that examines the dichotomy of “fast medicine” (which involves high medical use and spending) and what I refer to as “slow medicine”. It discusses ethical questions around which of these two frameworks really confers better “health” to patients – using examples from a real patient scenario of mine who was considering undergoing a relatively high-risk carotid endarterectomy. It then re-affirms the importance of primary care to conferring health and the ultimate value of primary care, or “slow medicine”. I believe it is a timely discussion as we continue to advocate for more primary care resources in our health care system.

中文翻译：

---

慢药

这是一篇评论文章，探讨了“快药”（涉及高医疗使用和支出）和我所说的“慢药”的二分法。它讨论了围绕这两个框架中的哪一个真正为患者带来更好的“健康”的伦理问题——使用来自我正在考虑接受相对高风险颈动脉内膜切除术的真实患者场景的例子。然后再次肯定初级保健对于赋予健康的重要性以及初级保健或“慢药”的最终价值。我相信这是一次及时的讨论，因为我们将继续倡导在我们的医疗保健系统中提供更多的初级保健资源。